Regulation of Tyrosine Hydroxylase Expression and Phosphorylation in Dopamine Transporter-Deficient Mice

ACS Chemical Neuroscience

Volumn 7, Issue 7, 2016, Pages 941-951

  Salvatore, Michael F ^a,b   Calipari, Erin S ^c,d   Jones, Sara R ^d  

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

dopamine neurotransmission; dopamine transporters; l DOPA; Tyrosine hydroxylase

Indexed keywords

DOPAMINE TRANSPORTER; SERINE; TYROSINE 3 MONOOXYGENASE; DOPAMINE; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SUBSTANTIA NIGRA; TURNOVER TIME; VENTRAL TEGMENTUM; ANIMAL; BIOSYNTHESIS; BRAIN; C57BL MOUSE; DEFICIENCY; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; NONPARAMETRIC TEST; PHOSPHORYLATION;

ANIMALS; BRAIN; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; GENE EXPRESSION REGULATION; LEVODOPA; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; SERINE; STATISTICS, NONPARAMETRIC; TYROSINE 3-MONOOXYGENASE;

EID: 84979561857     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/acschemneuro.6b00064     Document Type: Article

References (57)

1. Hoffman, A. F., Lupica, C. R., and Gerhardt, G. A. (1998) Dopamine transporter activity in the substantia nigra and striatum assessed by high-speed chronoamperometric recordings in brain slices J. Pharmacol. Exp. Ther. 287, 487-496
2. 2+ dependence and time course of somatodendritic dopamine release: substantia nigra versus striatum J. Neurosci. 21, 7841-7847
3. John, C. E. and Jones, S. R. (2006) Exocytotic release of dopamine in ventral tegmental area slices from C57BL/6 and dopamine transporter knockout mice Neurochem. Int. 49, 737-45 10.1016/j.neuint.2006.06.004
4. Ford, C. P., Gantz, S. C., Phillips, P. E. M., and Williams, J. T. (2010) Control of extracellular dopamine at dendrite and axon terminals J. Neurosci. 30, 6975-6983 10.1523/JNEUROSCI.1020-10.2010
5. Salvatore, M. F. and Pruett, B. S. (2012) Dichotomy of tyrosine hydroxylase and dopamine regulation between somatodendritc and terminal field areas of nigrostriatal and mesoaccumbens pathways PLoS One 7, e29867 10.1371/journal.pone.0029867
6. Haycock, J. W. and Haycock, D. A. (1991) Tyrosine hydroxylase in rat brain dopaminergic nerve terminals: Multiple-site phosphorylation in vivo and in synaptosomes J. Biol. Chem. 266, 5650-5657
7. Salvatore, M. F., Waymire, J. C., and Haycock, J. W. (2001) Depolarization-stimulated catecholamine biosynthesis: involvement of protein kinases and tyrosine hydroxylase phosphorylation sites in situ J. Neurochem. 79, 349-360 10.1046/j.1471-4159.2001.00593.x
8. Harada, K., Wu, J., Haycock, J. W., and Goldstein, M. (1996) Regulation of L-DOPA biosynthesis by site-specific phosphorylation of tyrosine hydroxylase in AtT-20 cells expressing wild-type and serine 40-substituted enzyme J. Neurochem. 67, 629-635 10.1046/j.1471-4159.1996.67020629.x
9. Nunez, C., Laorden, M. L., and Milanes, M. V. (2007) Regulation of serine (Ser)-31 and Ser40 tyrosine hydroxylase phosphorylation during morphine withdrawal in the hypothalamic paraventricular nucleus and nucleus tractus solitarius-A2 cell group: role of ERK1/2 Endocrinology 148, 5780-5793 10.1210/en.2007-0510
10. Dadalko, O. I., Siuta, M., Poe, A., Erreger, K., Matthies, H. J., Niswender, K., and Galli, A. (2015) mTORC2/rictor signaling disrupts dopamine-dependent behaviors via defects in striatal dopamine neurotransmission J. Neurosci. 35, 8843-8855 10.1523/JNEUROSCI.0887-15.2015
11. Salvatore, M. F. (2014) Ser31 tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion J. Neurochem. 129, 548-558 10.1111/jnc.12652
12. Haycock, J. W., Lew, J. Y., Garcia-Espana, A., Lee, K. Y., Harada, K., Meller, E., and Goldstein, M. (1998) Role of Serine-19 phosphorylation in regulating tyrosine hydroxylase studied with site- and phosphospecific antibodies and site-directed mutagenesis J. Neurochem. 71, 1670-1675 10.1046/j.1471-4159.1998.71041670.x
13. Chotibut, T., Davis, R. W., Arnold, J. C., Frenchek, Z., Gurwara, S., Bondada, V., Geddes, J. W., and Salvatore, M. F. (2014) Ceftriaxone increases glutamate uptake and reduces striatal tyrosine hydroxylase loss in 6-OHDA Parkinson's model Mol. Neurobiol. 49, 1282-1292 10.1007/s12035-013-8598-0
14. 2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum J. Neurochem. 72, 148-156 10.1046/j.1471-4159.1999.0720148.x
15. Lindgren, N., Xu, Z-Q.D., Lindskog, M., Herrera-Marschitz, M., Goiny, M., Haycock, J. W., Goldstein, M., Hokfelt, T., and Fisone, G. (2000) Regulation of tyrosine hydroxylase activity and phosphorylation at Ser19 and Ser40 via activation of glutamate NMDA receptors in rat striatum J. Neurochem. 74, 2470-2477 10.1046/j.1471-4159.2000.0742470.x
16. 2 receptors regulate tyrosine hydroxylase activity and phosphorylation at ser40 in rat striatum Eur. J. Neurosci. 13, 773-780 10.1046/j.0953-816x.2000.01443.x
17. Håkansson, K., Pozzi, L., Usiello, A., Haycock, J. W., Borrelli, E., and Fisone, G. (2004) Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol Eur. J. Neurosci. 20, 1108-1112 10.1111/j.1460-9568.2004.03547.x
18. Salvatore, M. F., Garcia-Espana, A., Goldstein, M., Deutch, A. Y., and Haycock, J. W. (2000) Stoichiometry of tyrosine hydroxylase phosphorylation in the nigrostriatal and mesolimbic systems in vivo: Effects of acute haloperidol and related compounds J. Neurochem. 75, 225-232 10.1046/j.1471-4159.2000.0750225.x
19. Keller, C. M., Salvatore, M. F., Pruett, B. S., Guerin, G. F., and Goeders, N. E. (2011) Biphasic dopamine regulation in mesoaccumbens pathway in response to non-contingent binge and escalating methamphetamine regimens in the Wistar rat Psychopharmacol 215, 513-526 10.1007/s00213-011-2301-9
20. Jones, S. R., Gainetdinov, R. R., Jaber, M., Giros, B., Wightman, R. M., and Caron, M. G. (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter Proc. Natl. Acad. Sci. U. S. A. 95, 4029-4034 10.1073/pnas.95.7.4029
21. Jones, S. R., Gainetdinov, R. R., Hu, X.-T., Cooper, D. C., Wightman, R. M., White, F. J., and Caron, M. G. (1999) Loss of autoreceptor functions in mice lacking the dopamine transporter Nat. Neurosci. 2, 649-655 10.1038/10204
22. Jaber, M., Dumartin, B., Sagne, C., Haycock, J. W., Roubert, C., Giros, B., Bloch, B., and Caron, M. G. (1999) Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter Eur. J. Neurosci 11, 3499-3511 10.1046/j.1460-9568.1999.00764.x
23. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., and Caron, M. G. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 379, 606-612 10.1038/379606a0
24. Spielewoy, C., Roubert, C., Hamon, M., Nosten-Bertrand, M., Betancur, C., and Giros, B. (2000) Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice Behav. Pharmacol. 11, 279-290 10.1097/00008877-200006000-00011
25. Trevitt, J. T., Carlson, B. B., Nowend, K., and Salamone, J. D. (2004) Substantia nigra pars reticulata is a highly potent site of action for the behavioral effects of the D1 antagonist SCH23390 in the rat Psychopharmacology 156, 32-41 10.1007/s002130100708
26. Andersson, D. R., Nissbrandt, H., and Bergquist, F. (2006) Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission Eur. J. Neurosci. 24, 617-624 10.1111/j.1460-9568.2006.04953.x
27. Kliem, M. A., Maidment, N. T., Ackerson, L. C., Chen, S., Smith, Y., and Wichmann, T. (2007) Activation of nigral and pallidal dopamine D1-like receptors modulates basal ganglia outflow in monkeys J. Neurophysiol. 98, 1489-1500 10.1152/jn.00171.2007
28. Pruett, B. S. and Salvatore, M. F. (2013) Nigral GFRα1 infusion in aged rats increases locomotor activity, nigral tyrosine hydroxylase, and dopamine content in synchronicity Mol. Neurobiol. 47, 988-999 10.1007/s12035-013-8397-7
29. Aumann, T. D., Egan, K., Lim, J., Boon, W. C., Bye, C. R., Chua, H. K., Baban, N., Parish, C. L., Bobrovskaya, L., Dickson, P. W., and Horne, M. K. (2011) Neuronal activity regulates expression of tyrosine hydroxylase in adult mouse substantia nigra pars compacta neurons J. Neurochem. 116, 646-658 10.1111/j.1471-4159.2010.07151.x
30. Jedynak, J. P., Ali, S. F., Haycock, J. W., and Hope, B. T. (2002) Acute administration of cocaine regulates the phosphorylation of ser19, -31, and -40 in tyrosine hydroxylase J. Neurochem. 82, 382-388 10.1046/j.1471-4159.2002.00982.x
31. Kawahata, I., Ohtaku, S., Tomioka, Y., Ichinose, H., and Yamakuni, T. (2015) Dopamine or biopterin deficiency potentiates phosphorylation at 40Ser and ubiquitination of tyrosine hydroxylase to be degraded by the ubiquitin proteasome system Biochem. Biophys. Res. Commun. 465, 53-58 10.1016/j.bbrc.2015.07.125
32. Shi, X., Woodward, W. R., and Habecker, B. A. (2012) Ciliary neurotrophic facor stimulates tyrosine hydroxylase activity J. Neurochem. 121, 700-704 10.1111/j.1471-4159.2012.07712.x
33. Vrana, K. E. and Roskoski, R. (1983) Tyrosine hydroxylase inactivation following cAMP-dependent phosphorylation activation J. Neurochem. 40, 1692-1700 10.1111/j.1471-4159.1983.tb08144.x
34. Salvatore, M. F., Fisher, B., Surgener, S. P., Gerhardt, G. A., and Rouault, T. A. (2005) Neurochemical investigations of dopamine neuronal systems in iron-regulatory protein 2 (IRP-2) knockout mice Mol. Brain Res. 139, 341-347 10.1016/j.molbrainres.2005.06.002
35. Calipari, E. S., Sun, H., Eldeeb, K., Luessen, D. J., Feng, X., Howlett, A. C., Jones, S. R., and Chen, R. (2014) Amphetamine self-administration attenuates dopamine D2 autoreceptor function Neuropsychopharmacology 39, 1833-1842 10.1038/npp.2014.30
36. Bobrovskaya, L., Gilligan, C., Bolster, E. K., Flaherty, J. J., Dickson, P. W., and Dunkley, P. R. (2007) Sustained phosphorylation of tyrosine hydroxylase at serine 40: a novel mechanism for maintenance of catecholamine synthesis J. Neurochem. 100, 479-489 10.1111/j.1471-4159.2006.04213.x
37. Ong, L. K., Guan, L., Stutz, B., Dickson, P. W., Dunkley, P. R., and Bobrovskaya, L. (2011) The effects of footshock and immobilization stress on tyrosine hydroxylase phosphorylation in the rat locus coeruleus and adrenal gland Neuroscience 192, 20-27 10.1016/j.neuroscience.2011.06.087
38. Geffen, L. B., Jessell, T. M., Cuello, A. C., and Iversen, L. L. (1976) Release of dopamine from dendrites in rat substantia nigra Nature 260, 258-260 10.1038/260258a0
39. Korf, J., Zieleman, M., and Westerink, B. H. (1976) Dopamine release in substantia nigra? Nature 260, 257-258 10.1038/260257a0
40. Cragg, S. J. and Greenfield, S. A. (1997) Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum J. Neurosci. 17, 5738-5748
41. Cragg, S. J., Rice, M. E., and Greenfield, S. A. (1997) Heterogeneity of electrically evoked dopamine release and reuptake in substantia nigra, ventral tegmental area, and striatum J. Neurophysiol. 77, 863-873
42. Leviel, V. (2011) Dopamine release mediated by the dopamine transporter, facts and consequences J. Neurochem. 118, 475-489 10.1111/j.1471-4159.2011.07335.x
43. Bergstrom, B. P., Sanberg, S. G., Andersson, M., Mithyantha, J., Carroll, F. I., and Garris, P. A. (2011) Functional reorganization of the presynaptic dopaminergic terminal in parkinsonism Neuroscience 193, 310-322 10.1016/j.neuroscience.2011.07.029
44. Budygin, E. A., Brodie, M. S., Sotnikova, T. D., Mateo, Y., John, C. E., Cyr, M., Gainetdinov, R. R., and Jones, S. R. (2004) Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine Proc. Natl. Acad. Sci. U. S. A. 101, 7781-7786 10.1073/pnas.0401418101
45. Carpenter, A. C., Saborido, T. P., and Stanwood, G. D. (2012) Development of hyperactivity and anxiety responses in dopamine transporter-deficient mice Dev. Neurosci. 34, 250-257 10.1159/000336824
46. Calipari, E. S., Ferris, M. J., Melchior, J. R., Bermejo, K., Salahpour, A., Roberts, D. C., and Jones, S. R. (2014) Methylphenidate and cocaine self-administration produce distinct dopamine terminal alterations Addict. Biol. 19, 145-155 10.1111/j.1369-1600.2012.00456.x
47. Salvatore, M. F., Hudspeth, O., Arnold, L. E., Wilson, P. E., Stanford, J. A., Mactutus, C. F., Booze, R. M., and Gerhardt, G. A. (2004) Prenatal cocaine exposure alters potassium-evoked dopamine relase dynamics Neuroscience 123, 481-490 10.1016/j.neuroscience.2003.10.002
48. Rice, M. E. and Patel, J. C. (2015) Somatodendritic dopamine release: recent mechanistic insights Philos. Trans. R. Soc., B 370, 20140185 10.1098/rstb.2014.0185
49. Beaulieu, J. M., Sotnikova, T. D., Gainetdinov, R. R., and Caron, M. G. (2006) Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice J. Biol. Chem. 281, 32072-32080 10.1074/jbc.M606062200
50. Rao, A., Sorkin, A., and Zahniser, N. R. (2013) Mice expressing markedly reduced striatal dopamine transporters exhibit increased locomotor activity, dopamine uptake turnover rate, and cocaine responsiveness Synapse 67, 668-677 10.1002/syn.21671
51. Kordower, J. H., Olanow, C. W., Dodiya, H. B., Chu, Y., Beach, T. G., Adler, C. H., Halliday, G. M., and Bartus, R. T. (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson's disease Brain 136, 2419-2431 10.1093/brain/awt192
52. Hansard, M. J., Smith, L. A., Jackson, M. J., Cheetham, S. C., and Jenner, P. (2002) Dopamine reuptake inhibition and failure to evoke dyskinesia in MPTP-treated primates Eur. J. Pharmacol. 451, 157-160 10.1016/S0014-2999(02)02268-9
53. Sun, H., Calipari, E. S., Beveridge, T. J., Jones, S. R., and Chen, R. (2015) The brain gene expression profile of dopamine D2/D3 receptors and associated signaling proteins following amphetamine self-administration Neuroscience 307, 253-261 10.1016/j.neuroscience.2015.08.053
54. Shin, E. J., Duong, C. X., Nguyen, T. X., Bing, G., Bach, J. H., Park, D. H., Nakayama, K., Ali, S. F., Kanthasamy, A. G., Cadet, J. L., Nabeshima, T., and Kim, H. J. (2011) PKC inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment Neurochem. Int. 59, 39-50 10.1016/j.neuint.2011.03.022
55. Kim, D. K., Tolliver, T. J., Huang, S. J., Martin, B. J., Andrews, A. M., Wichems, C., Holmes, A., Lesch, K. P., and Murphy, D. L. (2005) Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter Neuropharmacology 49, 798-810 10.1016/j.neuropharm.2005.08.010
56. Salvatore, M. F., Pruett, B. S., Dempsey, C., and Fields, V. (2012) Comprehensive profiling of dopamine regulation in susbtantia nigra and ventral tegmental area J. Visualized Exp. 10.3791/4171
57. Ji, J., Bourque, M., Di Paolo, T., and Dluzen, D. E. (2009) Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems Biochem. Pharmacol. 78, 1401-1411 10.1016/j.bcp.2009.07.004